Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 2 Terfenadine Induces Brugada Phenotype More Readily in Male Than Female RV Wedge Preparations
Each panel shows action potentials recorded from 2 epicardial sites and 1 endocardial site, together with a transmural electrocardiogram. Control recordings were obtained at a basic cycle length (BCL) of 2,000 ms, whereas terfenadine data were recorded at a BCL of 800 ms after a brief period of pacing at a BCL of 400 ms. (A) Terfenadine (5 µM)-induced, heterogeneous loss of action potential dome, ST-segment elevation, and phase 2 re-entry (arrow) in a male right ventricular (RV) wedge preparation. (B) Terfenadine fails to induce Brugada phenotype in a female RV wedge preparation. (C) Polymorphic VT triggered by spontaneous phase 2 re-entry in a male preparation. (D) Incidence of phase 2 re-entry in male (6 of 7) versus female (2 of 7) RV wedge preparations when perfused with 5 µM terfenadine for up to 2 h. Abbreviations as in Figure 1. Modified with permission from Antzelevitch (4).
|
